Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Smith & Nephew, Inc.

Approvalsnovel device granted (FDA De Novo)6 Jul 2026

Smith & Nephew, Inc.

6 Jul 2026: Novel device granted (FDA De Novo) · TESSA Spatial Surgery System; INTELLIO Tablet (72205455). Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
6 Jul 2026
Device
TESSA Spatial Surgery System; INTELLIO Tablet (72205455)
Specialty
Orthopedic
Product Code
SIQ
Country
United States
Location
Andover, MA
Submitted
2025-08-22
Reference
DEN250037
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Smith & Nephew, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Smith & Nephew, Inc. in our registers.

More in Orthopedic

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.